PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11748674-6	2001	On the other hand, cells treated with ELF and/or TPA displayed a hyperphosphorylated Cx43 band (P(3)).	Tetradecanoylphorbol Acetate	49-52	gap junction protein, alpha 1	Mus musculus	85-89	
12740021-7	2003	In addition, cAMP and TPA reduced the surface membrane labeling for Cx43, whereas staurosporin increased it.	Tetradecanoylphorbol Acetate	22-25	gap junction protein, alpha 1	Mus musculus	68-72	
11748674-5	2001	Western blot analysis using Cx43 specific antibodies showed obviously decreasing non phosphorylated Cx43 (P(0)) induced by ELF and/or TPA exposure.	Tetradecanoylphorbol Acetate	134-137	gap junction protein, alpha 1	Mus musculus	28-32	
11748674-5	2001	Western blot analysis using Cx43 specific antibodies showed obviously decreasing non phosphorylated Cx43 (P(0)) induced by ELF and/or TPA exposure.	Tetradecanoylphorbol Acetate	134-137	gap junction protein, alpha 1	Mus musculus	100-104	
9799444-9	1998	Exposure of 42GPA9 cells for 24 h to cAMP and 12-O-tetradecanoylphorbol-13-acetate greatly reduces the Cx43 staining at cell-cell contacts and concomitantly increases the cytoplasmic staining, suggesting that these agents alter the trafficking of Cx43 to the plasma membrane.	Tetradecanoylphorbol Acetate	46-82	gap junction protein, alpha 1	Mus musculus	103-107	
10694746-6	2000	The tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA), a protein kinase C (PKC) activator, increased the phosphorylation of Cx43, but decreased Cx43 positive spots.	Tetradecanoylphorbol Acetate	19-55	gap junction protein, alpha 1	Mus musculus	132-136	
10694746-6	2000	The tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA), a protein kinase C (PKC) activator, increased the phosphorylation of Cx43, but decreased Cx43 positive spots.	Tetradecanoylphorbol Acetate	19-55	gap junction protein, alpha 1	Mus musculus	152-156	
10694746-6	2000	The tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA), a protein kinase C (PKC) activator, increased the phosphorylation of Cx43, but decreased Cx43 positive spots.	Tetradecanoylphorbol Acetate	57-60	gap junction protein, alpha 1	Mus musculus	132-136	
10694746-6	2000	The tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA), a protein kinase C (PKC) activator, increased the phosphorylation of Cx43, but decreased Cx43 positive spots.	Tetradecanoylphorbol Acetate	57-60	gap junction protein, alpha 1	Mus musculus	152-156	
9799444-9	1998	Exposure of 42GPA9 cells for 24 h to cAMP and 12-O-tetradecanoylphorbol-13-acetate greatly reduces the Cx43 staining at cell-cell contacts and concomitantly increases the cytoplasmic staining, suggesting that these agents alter the trafficking of Cx43 to the plasma membrane.	Tetradecanoylphorbol Acetate	46-82	gap junction protein, alpha 1	Mus musculus	247-251	
9258746-4	1997	The early (< 1 h) inhibition by TPA was consistent with an increase in the phosphorylation of connexin 43 (Cx43).	Tetradecanoylphorbol Acetate	35-38	gap junction protein, alpha 1	Mus musculus	97-108	
9258746-4	1997	The early (< 1 h) inhibition by TPA was consistent with an increase in the phosphorylation of connexin 43 (Cx43).	Tetradecanoylphorbol Acetate	35-38	gap junction protein, alpha 1	Mus musculus	110-114